A detailed history of Israel Englander (Millennium Management LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Millennium Management LLC holds 159,739 shares of RDY stock, worth $2.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
159,739
Previous 332,502 51.96%
Holding current value
$2.5 Million
Previous $25.3 Million 49.9%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$75.41 - $84.21 $13 Million - $14.5 Million
-172,763 Reduced 51.96%
159,739 $12.7 Million
Q2 2024

Aug 14, 2024

BUY
$68.26 - $76.19 $8.63 Million - $9.64 Million
126,472 Added 61.39%
332,502 $25.3 Million
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $12.6 Million - $14.5 Million
186,471 Added 953.38%
206,030 $15.1 Million
Q4 2023

Feb 14, 2024

SELL
$64.27 - $69.9 $19.8 Million - $21.6 Million
-308,379 Reduced 94.04%
19,559 $1.36 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $11.1 Million - $13.1 Million
207,955 Added 173.32%
327,938 $20.7 Million
Q1 2023

May 15, 2023

BUY
$51.63 - $56.93 $5.09 Million - $5.61 Million
98,624 Added 461.74%
119,983 $6.83 Million
Q4 2022

Feb 14, 2023

BUY
$51.15 - $57.45 $305,007 - $342,574
5,963 Added 38.73%
21,359 $1.11 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $1.89 Million - $2.17 Million
-37,848 Reduced 71.08%
15,396 $806,000
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $30.1 Million - $35.3 Million
-607,150 Reduced 91.94%
53,244 $2.95 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $19.5 Million - $26.4 Million
404,639 Added 158.21%
660,394 $36.8 Million
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $3.01 Million - $3.4 Million
50,594 Added 24.66%
255,755 $16.7 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $9.34 Million - $11.7 Million
155,138 Added 310.13%
205,161 $13.4 Million
Q2 2021

Aug 16, 2021

SELL
$62.12 - $74.2 $16.7 Million - $19.9 Million
-268,844 Reduced 84.31%
50,023 $3.68 Million
Q1 2021

May 17, 2021

BUY
$57.98 - $73.08 $2.28 Million - $2.88 Million
39,362 Added 14.08%
318,867 $19.6 Million
Q4 2020

Feb 16, 2021

BUY
$62.61 - $71.29 $17 Million - $19.4 Million
271,572 Added 3423.32%
279,505 $19.9 Million
Q3 2020

Nov 16, 2020

BUY
$51.39 - $72.41 $407,676 - $574,428
7,933 New
7,933 $552,000
Q2 2020

Aug 14, 2020

SELL
$39.55 - $54.65 $368,289 - $508,900
-9,312 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$34.75 - $45.85 $1.98 Million - $2.61 Million
-57,024 Reduced 85.96%
9,312 $376,000
Q4 2019

Feb 14, 2020

BUY
$36.66 - $41.78 $265,638 - $302,737
7,246 Added 12.26%
66,336 $2.69 Million
Q3 2019

Nov 14, 2019

BUY
$34.82 - $39.26 $2.06 Million - $2.32 Million
59,090 New
59,090 $2.24 Million
Q2 2019

Aug 14, 2019

SELL
$36.05 - $42.76 $1.13 Million - $1.34 Million
-31,282 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$35.77 - $40.57 $1.12 Million - $1.27 Million
31,282 New
31,282 $1.27 Million
Q4 2018

Feb 14, 2019

SELL
$31.89 - $38.44 $5.94 Million - $7.16 Million
-186,224 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$29.25 - $36.73 $3.47 Million - $4.36 Million
-118,653 Reduced 38.92%
186,224 $6.44 Million
Q2 2018

Aug 14, 2018

BUY
$28.49 - $35.06 $8.26 Million - $10.2 Million
289,942 Added 1941.36%
304,877 $9.82 Million
Q1 2018

May 15, 2018

SELL
$31.93 - $39.54 $285,933 - $354,080
-8,955 Reduced 37.48%
14,935 $488,000
Q4 2017

Feb 14, 2018

BUY
$34.15 - $37.62 $606,606 - $668,244
17,763 Added 289.91%
23,890 $897,000
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $184,483 - $231,110
6,127
6,127 $219,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.